Savara (SVRA) Gains from Investment Securities (2010 - 2026)
Savara (SVRA) reported Gains from Investment Securities of $12.9 million for Q1 2026, up 17045.9% year-over-year from N/an in Q1 2025, and down 2.79% on a QoQ basis from $13.2 million in Q4 2025.
Savara (SVRA) has 17 years of Gains from Investment Securities data on file, last reported at $12.9 million in Q1 2026.
- Quarterly Gains from Investment Securities rose 17045.9% year-over-year to $12.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $12.9 million (up 17045.9% YoY) and the FY2025 annual result came in at $13.2 million, down 2.3% from the prior year.
- Gains from Investment Securities retreated to $12.9 million in Q1 2026 per SVRA's latest filing, from $13.2 million in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $13.6 million in Q4 2024 and bottomed at $381.0 in Q1 2024.
- The 5-year median for Gains from Investment Securities is $35718.0 (2025), against an average of $4.2 million.
- The widest annual swing landed in 2022, when Gains from Investment Securities plunged 99.99%; it then surged 59909.41% in 2025.
- Tracing SVRA's Gains from Investment Securities over 5 years: stood at $7.9 million in 2022, then rose by 21.43% to $9.6 million in 2023, then jumped by 40.71% to $13.6 million in 2024, then retreated by 2.3% to $13.2 million in 2025, then decreased by 2.79% to $12.9 million in 2026.
- Per Business Quant, the three latest SVRA Gains from Investment Securities figures stand at $12.9 million (Q1 2026), $13.2 million (Q4 2025), and $13.2 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Savara | 1.30 Bn | 1.30 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.87 Mn |
| Mar 31, 2026 | 12.87 Mn |
| Dec 31, 2025 | 13.24 Mn |
| Dec 31, 2025 | 13.24 Mn |
| Sep 30, 2025 | 13.21 Mn |
| Sep 30, 2025 | 13.21 Mn |
| Jun 30, 2025 | 35,718.00 |
| Jun 30, 2025 | 35,718.00 |
| Mar 31, 2025 | 75,083.00 |
| Mar 31, 2025 | 75,083.00 |
| Dec 31, 2024 | 13.55 Mn |
| Dec 31, 2024 | 13.55 Mn |
| Sep 30, 2024 | 22,013.00 |
| Sep 30, 2024 | 22,013.00 |
| Jun 30, 2024 | 381.00 |
| Jun 30, 2024 | 381.00 |
| Mar 31, 2024 | 381.00 |
| Mar 31, 2024 | 381.00 |
| Dec 31, 2023 | 9.63 Mn |
| Dec 31, 2023 | 9.63 Mn |
| Sep 30, 2023 | 51,042.00 |
| Sep 30, 2023 | 51,042.00 |
| Jun 30, 2023 | 468.00 |
| Jun 30, 2023 | 468.00 |
| Mar 31, 2023 | 551.00 |
| Mar 31, 2023 | 551.00 |
| Dec 31, 2022 | 7.93 Mn |
| Dec 31, 2022 | 7.93 Mn |
| Sep 30, 2022 | 442.00 |
| Sep 30, 2022 | 442.00 |
| Jun 30, 2022 | 401.00 |
| Jun 30, 2022 | 401.00 |
| Mar 31, 2022 | 720.00 |
| Mar 31, 2022 | 720.00 |
| Dec 31, 2021 | 6.22 Mn |
| Dec 31, 2021 | 6.22 Mn |
| Sep 30, 2021 | 670,000.00 |
| Sep 30, 2021 | 670,000.00 |
| Jun 30, 2021 | 245,000.00 |
| Jun 30, 2021 | 245,000.00 |
| Mar 31, 2021 | 5.34 Mn |
| Mar 31, 2021 | 5.34 Mn |
| Dec 31, 2020 | 6.24 Mn |
| Dec 31, 2020 | 6.24 Mn |
| Sep 30, 2020 | 721,866.00 |
| Sep 30, 2020 | 721,866.00 |
| Jun 30, 2020 | 4.40 Mn |
| Jun 30, 2020 | 4.40 Mn |
| Mar 31, 2020 | 4.47 Mn |
| Mar 31, 2020 | 4.47 Mn |
| Dec 31, 2019 | -260,000.00 |
| Dec 31, 2019 | -260,000.00 |
| Sep 30, 2019 | 3.25 Mn |
| Sep 30, 2019 | 3.25 Mn |
| Jun 30, 2019 | 3.30 Mn |
| Jun 30, 2019 | 3.30 Mn |
| Mar 31, 2019 | 90,000.00 |
| Mar 31, 2019 | 90,000.00 |
| Dec 31, 2018 | 135,000.00 |
| Dec 31, 2018 | 135,000.00 |
| Sep 30, 2018 | 123,850.00 |
| Sep 30, 2018 | 123,850.00 |
| Jun 30, 2018 | 31,720.00 |
| Jun 30, 2018 | 31,720.00 |
| Mar 31, 2018 | -134,000.00 |
| Mar 31, 2018 | -134,000.00 |
| Dec 31, 2017 | 132,000.00 |
| Dec 31, 2017 | 132,000.00 |
| Sep 30, 2017 | 1.61 Mn |
| Sep 30, 2017 | 1.61 Mn |
| Jun 30, 2017 | 386,034.00 |
| Jun 30, 2017 | 386,034.00 |
| Mar 31, 2017 | 2.00 Mn |
| Mar 31, 2017 | 2.00 Mn |
| Dec 31, 2016 | 2.13 Mn |
| Dec 31, 2016 | 2.13 Mn |
| Sep 30, 2016 | 188,290.00 |
| Sep 30, 2016 | 188,290.00 |
| Jun 30, 2016 | 1.22 Mn |
| Jun 30, 2016 | 1.22 Mn |
| Mar 31, 2016 | 7.83 Mn |
| Mar 31, 2016 | 7.83 Mn |
| Dec 31, 2015 | 1.08 Mn |
| Dec 31, 2015 | 1.08 Mn |
| Sep 30, 2015 | 22.46 Mn |
| Sep 30, 2015 | 22.46 Mn |
| Jun 30, 2015 | 12.52 Mn |
| Jun 30, 2015 | 12.52 Mn |
| Mar 31, 2015 | 2.84 Mn |
| Mar 31, 2015 | 2.84 Mn |
| Dec 31, 2014 | 13.62 Mn |
| Dec 31, 2014 | 13.62 Mn |
| Sep 30, 2014 | 1.12 Mn |
| Sep 30, 2014 | 1.12 Mn |
| Jun 30, 2014 | 34,329.00 |
| Jun 30, 2014 | 34,329.00 |
| Mar 31, 2014 | 9.49 Mn |
| Mar 31, 2014 | 9.49 Mn |
| Dec 31, 2013 | 7.30 Mn |
| Dec 31, 2013 | 7.30 Mn |
| Sep 30, 2013 | 203,144.00 |
| Sep 30, 2013 | 203,144.00 |
| Jun 30, 2013 | -199,750.00 |
| Jun 30, 2013 | -199,750.00 |
| Mar 31, 2012 | -4,503.00 |
| Mar 31, 2012 | -4,503.00 |
| Mar 31, 2011 | 2,973.00 |
| Mar 31, 2011 | 2,973.00 |
| Dec 31, 2010 | -2,250.00 |
| Dec 31, 2010 | -2,250.00 |